Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00282204
Other study ID # ACTRN012605000018617
Secondary ID
Status Completed
Phase Phase 2/Phase 3
First received January 24, 2006
Last updated June 28, 2012
Start date December 2005
Est. completion date December 2010

Study information

Verified date December 2010
Source Women's and Children's Hospital, Australia
Contact n/a
Is FDA regulated No
Health authority Australia: Human Research Ethics CommitteeAustralia: National Health and Medical Research Council
Study type Interventional

Clinical Trial Summary

Antenatal hypnosis is associated with a reduced need for pharmacological interventions during childbirth. This trial seeks to determine the efficacy or otherwise of antenatal group hypnosis preparation for childbirth in late pregnancy.


Description:

Background: Although medical interventions play an important role in preserving lives and maternal comfort they have become increasingly routine in normal childbirth. This may increase the risk of associated complications and a less satisfactory birth experience. Antenatal hypnosis is associated with a reduced need for pharmacological interventions during childbirth. This trial seeks to determine the efficacy or otherwise of antenatal group hypnosis preparation for childbirth in late pregnancy.

Methods / Design: A single centre, randomised controlled trial using a 3 arm parallel group design in the largest tertiary maternity unit in South Australia. Group 1 participants receive antenatal hypnosis training in preparation for childbirth administered by a qualified hypnotherapist with the use of an audio compact disc on hypnosis for re-enforcement; Group 2 consists of antenatal hypnosis training in preparation for childbirth using an audio compact disc on hypnosis administered by a nurse with no training in hypnotherapy; Group 3 participants continue with their usual preparation for childbirth with no additional intervention. Women > 34 < 39 weeks gestation, with a singleton, viable fetus, vertex presentation, who are not in active labour or planning a vaginal birth are eligible to participate. Allocation concealment is achieved using telephone randomisation. Participants assigned to hypnosis groups are trained as near as possible to 37 weeks gestation. Group allocations are concealed from treating obstetricians, anaesthetists, midwives and those personnel collecting and analysing data. Our sample size of 135 women / group gives the study 80% power to detect a clinically relevant fall of 20% in the number of women requiring pharmacological analgesia - the primary endpoint. We estimate that approximately 5-10% of women will deliver prior to receiving their allocated intervention. We plan to recruit 150 women / group and perform interim analyses when 150 and 300 participants have been recruited. All participants will be analysed according to the "Intention to treat" principle with comprehensive pre-planned cost- benefit and subgroup analyses.

Discussion: If effective, hypnosis would be a simple, inexpensive way to improve the childbirth experience, reduce complications associated with pharmacological interventions, yield cost savings in maternity care, and provide evidence to guide clinical practice.


Recruitment information / eligibility

Status Completed
Enrollment 448
Est. completion date December 2010
Est. primary completion date December 2010
Accepts healthy volunteers No
Gender Female
Age group N/A and older
Eligibility Inclusion Criteria:

- women > 34 < 39 weeks gestation; singleton, viable fetus, vertex presentation, who are not in active labour (active labour is defined as cervical effacement and dilatation associated with regular uterine contractions) and who are planning a vaginal birth.

Exclusion Criteria:

- Previous hypnosis preparation for childbirth;

- poor understanding of English requiring translator;

- women who are already enrolled in another pregnancy trial where analgesia requirements are an outcome measure;

- active psychological or psychiatric problems such as: active depression requiring treatment by a psychiatrist;

- schizophrenia;

- prior psychosis;

- severe intellectual disability.

- Women with pain caused by specific pathological entities such as: congenital neuromuscular disorders; spina bifida; metastatic disease; osteoporosis; rheumatoid arthritis; fractures,are also excluded

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Prevention


Related Conditions & MeSH terms


Intervention

Behavioral:
antenatal hypnosis + audio compact disc on hypnosis

Audio compact disc on hypnosis


Locations

Country Name City State
Australia Women's and Children's Hospital Adelaide South Australia

Sponsors (1)

Lead Sponsor Collaborator
Women's and Children's Hospital, Australia

Country where clinical trial is conducted

Australia, 

References & Publications (1)

Cyna AM, Andrew MI, Robinson JS, Crowther CA, Baghurst P, Turnbull D, Wicks G, Whittle C. Hypnosis Antenatal Training for Childbirth (HATCh): a randomised controlled trial [NCT00282204]. BMC Pregnancy Childbirth. 2006 Mar 5;6:5. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary The use of pharmacological analgesia during labour and childbirth will be collected from the birth register where all analgesia is documented by the attending midwife Within 24 hours of the birth Yes
Secondary 1. Maternal rating of the overall pain experienced during labour and childbirth Usually within 48 hours or before discharge from hospital No
Secondary 2. Mode of delivery Within 24 hours of the birth Yes
Secondary 3. Use of oxytocics Within 24 hours of the birth Yes
Secondary 4. Postnatal depression At 6 weeks and 6 months postnatal Yes
Secondary 5. Maternal anxiety At 6 weeks and 6 months postnatal No
Secondary 6. Neonatal Apgar score at 5 minutes < 7 within 24 hours of birth Yes
Secondary 7. Maternal admission to the High Dependency Unit (HDU) or the Intensive Care Unit (ICU) within 24 hours of birth Yes
Secondary 8. Maternal rating whether the birth experience was. Worse / better / same as expected within 24 hours of birth No
Secondary 9. Maternal rating of control during the labour during the birth within 24 hours of birth No
Secondary 10. Maternal rating whether the birth was rated positive or negative experience within 24 hours of birth No
Secondary 11. Length of neonatal nursery stay within 24 hours of birth Yes
Secondary 12. Length of maternal stay in hospital within 6 months of the birth Yes
Secondary 13. Number of women breast feeding at discharge from hospital and at 6 weeks and 6 months 6 months after birth No
See also
  Status Clinical Trial Phase
Completed NCT03442582 - Afluria Pregnancy Registry
Terminated NCT02161861 - Improvement of IVF Fertilization Rates, by the Cyclic Tripeptide FEE - Prospective Randomized Study N/A
Not yet recruiting NCT05934318 - L-ArGinine to pRevent advErse prEgnancy Outcomes (AGREE) N/A
Enrolling by invitation NCT05415371 - Persistent Poverty Counties Pregnant Women With Medicaid N/A
Completed NCT04548102 - Effects of Fetal Movement Counting on Maternal and Fetal Outcome Among High Risk Pregnant Woman N/A
Completed NCT03218956 - Protein Requirement During Lactation N/A
Completed NCT02191605 - Computer-delivered Screening & Brief Intervention for Marijuana Use in Pregnancy N/A
Completed NCT02223637 - Meningococcal Quadrivalent CRM-197 Conjugate Vaccine Pregnancy Registry
Recruiting NCT06049953 - Maternal And Infant Antipsychotic Study
Completed NCT02577536 - PregSource: Crowdsourcing to Understand Pregnancy
Not yet recruiting NCT06336434 - CREATE - Cabotegravir & Rilpivirine Antiretroviral Therapy in Pregnancy Phase 1/Phase 2
Not yet recruiting NCT04786587 - Alcohol Self-reporting During Pregnancy. AUTOQUEST Study.
Not yet recruiting NCT05412238 - Formulation and Evaluation of the Efficacy of Macro- and Micronutrient Sachets on Pregnant Mothers and Children Aged 6-60 Months N/A
Not yet recruiting NCT05028387 - Telemedicine Medical Abortion Service Using the "No-test" Protocol in Ukraine and Uzbekistan.
Completed NCT02783170 - Safety and Immunogenicity of Simultaneous Tdap and IIV in Pregnant Women Phase 4
Completed NCT02683005 - Study of Hepatitis C Treatment During Pregnancy Phase 1
Recruiting NCT02507180 - Safely Ruling Out Deep Vein Thrombosis in Pregnancy With the LEFt Clinical Decision Rule and D-Dimer
Recruiting NCT02564250 - Maternal Metabolism and Pregnancy Outcomes in Obese Pregnant Women N/A
Recruiting NCT02619188 - Nutritional Markers in Normal and Hyperemesis Pregnancies N/A
Completed NCT02379728 - Ghana PrenaBelt Trial: A Positional Therapy Device to Reduce Still-Birth N/A